Tramadol reduced chronic pain but the effect was below a predefined threshold, data from 19 trials suggested. Serious adverse events were higher with tramadol versus placebo. Most trials had a high ...

Tramadol was approved by the U.S. Food and Drug Administration in March 1995 as a noncontrolled substance but was reclassified in 2014 as a schedule IV medication under the Controlled Substances Act ...

Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new study suggests that the medication’s potential risks outweigh its “limited” benefits for chronic ...

Add Yahoo as a preferred source to see more of our stories on Google. According to manufacturer records, the new study says, nearly 12 million daily doses of tramadol were consumed worldwide from 1990 ...